Len Yaffe
Stoc*Doc Partners
Len Yaffe has spent 30 years analyzing the healthcare sector, and he currently runs Stoc*Doc Partners, a healthcare hedge fund in San Francisco. He holds an MD from the Feinberg School of Medicine, Northwestern University.
Recent Quotes
"There are few stocks with similar upside potential to DRRX."
—
Len Yaffe, Seeking Alpha
(3/23/18)
more >
"I continue to highlight DRRX, whose DUR-928 looks very promising, albeit in early stage clinical trials."
—
Len Yaffe, Stoc*Doc Partners
(12/20/16)
more >
"The recent weakness in pharmaceutical stocks affords an excellent buying opportunity in select names with promising pipelines, including DRRX.
—
The Life Sciences Report Article by Dr. Len Yaffe
(11/2/16)
more >
"I am impressed with the very early data on DRRX's endogenous small molecule, DUR-928."
—
Len Yaffe, Stoc*Doc Partners
(10/20/16)
more >
